| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |